BXCL701 Phase 1 R/R Acute Myeloid Leukemia or Myelodysplastic Syndrome
Conditions: Acute Myeloid Leukemia; Myelodysplastic Syndrome With Excess Blasts-2 Intervention: Drug: BXCL701 Sponsor: Eric Stephen Winer, MD Not yet recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials